Why BGPT?
logo

The Evidence Layer for Scientific AI

Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what the science actually supports before you trust the answer.

Press Enter ↵ to search evidence



    Explore by Goal












     Quick Explanation


    Orthogonal validation checklist for epitranscriptomics — best-evidence synthesis

    I assembled a concise, evidence‑grounded orthogonal validation checklist built from recent nanopore and chemical/enzymatic orthogonal-method studies (SWARM, Nano‑Mod‑Amp, Ψ‑co‑mAFiA, DRAM‑seq, DRUGS review). Use the full checklist to design multi-layer validation experiments that reduce false positives from signal crosstalk, chemistry biases, and ML overfitting. Key pillars: (1) orthogonal chemistry/enzymatic mapping, (2) synthetic IVT standards & calibration for stoichiometry, (3) perturbation (writer/eraser KO/KD/OE), (4) single-molecule co-detection controls, (5) structural probing and MPRA, (6) cross-chemistry sequencing replicates, and (7) benchmarking/training transparency. See detailed evidence and interactive figure below.

    Primary evidence: SWARM (multi-mod single-molecule nanopore method) validates cross‑mod calling strategies and stresses orthogonal benchmarks ; Nano‑Mod‑Amp demonstrates nanopore + MPRA + SHAPE orthogonal validation for Ψ (PUS7) .




     Long Explanation


    Best‑Evidence Orthogonal Validation Checklist for Epitranscriptomics

    Visual summary (evidence-sourced pillars)

    1. Orthogonal chemical/enzymatic mapping: Use an independent chemistry or enzyme-based assay (e.g., GLORI for m6A, BACS/MS or bisulfite for Ψ/m5C, DRAM-seq for m5C) to confirm sites called by nanopore methods
    2. Synthetic IVT standards & calibration: Build sequence-context specific synthetic controls to calibrate stoichiometry and basecalling biases (UGUAG vs UCUAR differences shown in Nano‑Mod‑Amp)
    3. Perturbation tests (writers/erasers): KO/KD/OE of writer or eraser proteins and measure site-level changes (e.g., METTL3 KO, PUS7 KD/OE, TRUB1 KD) to show causality; SWARM and Ψ‑co‑mAFiA rely on such perturbations for training/validation
    4. Single‑molecule cross‑mod checks & crosstalk mitigation: Train or validate models with non-target modifications present to suppress signal crosstalk and confirm per-read co-occurrence patterns (SWARM approach)
    5. Structure probing and reporter assays (functional context): Use SHAPE/SHAPE‑MaP and MPRA to test structural dependence and sequence windows (e.g., Nano‑SHAPE‑Amp and MPRA in Nano‑Mod‑Amp study showed Pupup signature and cell-type specificity)
    6. Cross-chemistry & multi-platform replicates: Repeat calls across nanopore chemistries, basecallers, and sequencing platforms and compare to LC‑MS/nucleoside MS when possible (reviewed best-practices)
    7. Transparent training/benchmark datasets & negative controls: Publish IVT controls, KO/KD datasets, and withheld test sets; use true negatives (IVT unmodified) and near‑neighbor modified controls to estimate false positive rates (essential for supervised ML like Ψ-co-mAFiA and SWARM)
    8. Stoichiometry reporting and calibration curves: Report calibrated stoichiometries with sequence-context calibration curves and synthetic standards (Nano‑Mod‑Amp demonstrated median 31% corrected stoichiometry and wide site range)
    9. Functionally informative downstream assays: When asserting biological roles, complement mapping with functional readouts (translation, splicing, stability) and rescue experiments after writer KO/OE; e.g., TRUB1 Ψ near exon‑exon boundaries tied to splicing dependency in SWARM data
    10. Statistical rigor & replicate transparency: Report biological replicates, multiple cell/tissue contexts, multiple sequencing runs, BH/FDR corrections and per-site p-values; both Nano‑Mod‑Amp and SWARM used replicates and multiple datasets to quantify reproducibility

    Quantitative visual: counts / capability by method (evidence-derived)

    Evidence-linked checklist (compact actionable form)

    Checklist ItemWhy (evidence)Minimal successful criteria
    Orthogonal chemistry/enzyme mappingDRAM‑seq enzymatic marking and SWARM/BACS/MS/GLORI cross-checks reduce method-specific false positivesAt least one independent chemistry or enzymatic assay confirms the site with consistent directionality (loss/gain on KO/OE)
    Synthetic IVT standardsNano‑Mod‑Amp used UNUAR/UNΨAR standards to correct motif-dependent stoichiometry biasesCalibration curve per-motif with IVT series and measurable correction factor
    Perturbation (writer/eraser KO/KD/OE)SWARM, Ψ‑co‑mAFiA, and Nano‑Mod‑Amp used perturbations as ground truth for supervised modelsSite-level change (statistically significant) observed across replicates post-perturbation
    Single-molecule per-read validationSWARM and Ψ-co-mAFiA demonstrate per-read probabilities and co-occurrence analysis to identify crosstalkPer-read probability distributions and false-positive estimates reported
    Structure & context assaysNano‑Mod‑Amp SHAPE + MPRA linked Pupup signature to higher Ψ stoichiometry and cell-type specificitySHAPE/SHAPE‑MaP shows consistent local structural signature vs control; MPRA recapitulation in vitro or in cell
    Cross-chemistry replicatesDeep-learning review emphasizes basecaller/chemistry effects and need for multiple chemistriesSame site observed across at least two chemistries/basecaller versions or supported by MS
    Transparent datasets & negative controlsΨ-co-mAFiA and SWARM rely on IVT and held-out test sets; publications provide GitHub and accession linksPublic IVT/KO datasets and held-out test set available for independent benchmarking
    Stoichiometry reportingNano‑Mod‑Amp reports absolute stoichiometry after calibration; SWARM reports per-read probabilitiesProvide calibrated stoichiometry with 95% CI or per-read probability distributions
    Statistical rigorNano‑Mod‑Amp used multi-way ANOVA and BH correction; replicate coverage mattersProvide biological replicates (>=3 where possible), coverage thresholds, BH-corrected p-values

    Caveats, blindspots & how to address them

    • Supervised ML models depend on training-label quality; expand IVT/perturbation datasets across sequence contexts to reduce label bias .
    • Nanopore basecalling/chemistry/version changes alter signals — always re-run benchmarks when updating basecallers/chemistries .
    • MPRA and overexpression contexts can misrepresent endogenous regulation — combine endogenous perturbations when possible (CRISPR KO, native locus editing) .
    • m5C ground truth remains limited; DRAM‑seq provides a strong enzymatic orthogonal approach but has ~40 nt resolution and relies on reader specificity — validate with NSUN KOs and orthogonal BS-seq/MS where possible .

    Immediate recommended experimental workflow (evidence-based minimal design)

    1. Design IVT synthetic series for target motifs (modified and unmodified) spanning nearest-neighbor contexts (use Nano‑Mod‑Amp lesson on UGUAG/UNUAR) for calibration .
    2. Collect endogenous RNA from at least two cell/tissue contexts; perform nanopore direct RNA sequencing (multiple chemistries if possible) and apply a read-level model trained with non-target modifications (SWARM best practice) .
    3. Perform perturbation (writer KO/KD and OE where feasible); call differential sites with BH correction and require reproducibility across replicates (>=3) .
    4. Use at least one orthogonal mapping (chemical or enzymatic): e.g., GLORI/BACS for m6A/Ψ, DRAM‑seq for m5C, bisulfite‑BID approaches for Ψ as in Nano‑BID‑Amp, and confirm with LC‑MS for bulk stoichiometry where possible .
    5. Probe structure (SHAPE/NAI) and run MPRA for candidate windows to confirm structural dependence and trans-acting RBP contributions (Nano‑Mod‑Amp example: Pupup signature and CELF/MBNL enrichment) .

    What would falsify mapped sites / change confidence?

    Confidence in a site would drop if: (a) orthogonal chemistry/enzymatic mapping fails to reproduce the site while coverage and replicates are adequate; (b) calibrated IVT series indicate nanopore signal is explained by sequence context rather than true modification; (c) writer KO/OE perturbation produces no consistent site-level change across replicates; or (d) single‑molecule per-read probabilities show values indistinguishable from background noise after crosstalk training. These falsification tests are explicit in SWARM and Nano‑Mod‑Amp methodologies .

    Primary sources used (selected)



    Feedback:    

    Updated: March 17, 2026

     Top Data Sources ExportMCP


     Analysis Wizard



    Generating per-site validation summary tables (coverage, per-read probability distributions, IVT calibration offsets) from nanopore output and orthogonal assay files to compute corrected stoichiometries using SWARM/Nano‑Mod‑Amp derived calibrations.



     Hypothesis Graveyard


    Hypothesis: Nanopore per-read co-occurrence necessarily equals biological co-modification — falsified because SWARM shows read-level crosstalk and supervised ML can misattribute signals without orthogonal assays .


    Hypothesis: One nanopore model trained on IVT is sufficient for all tissues/species — weakened by SWARM and review: generalizability is limited and cross-species/tissue IVT diversity is needed .

     Science Art


    Best Evidence: Assemble orthogonal validation checklist for epitranscriptomics Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending